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Pseudomonas putida strains are ubiquitous in soil and water but have also been
reported as opportunistic human pathogens capable of causing nosocomial infections.
In this study we describe the multilocus sequence typing of four P. putida strains
(HB13667, HB8234, HB4184, and HB3267) isolated from in-patients at the Besançon
Hospital (France). The four isolates (in particular HB3267) were resistant to a number of
antibiotics. The pathogenicity and virulence potential of the strains was tested ex vivo
and in vivo using different biological models: human tissue culture, mammalian tissues,
and insect larvae. Our results showed a significant variability in the ability of the four
strains to damage the host; HB13667 did not exhibit any pathogenic traits, HB4184
caused damage only ex vivo in human tissue cultures, and HB8234 had a deleterious
effect in tissue culture and in vivo on rat skin, but not in insect larvae. Interestingly, strain
HB3267 caused damage in all the model systems studied. The putative evolution of
these strains in medical environments is discussed.
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Introduction
Bacteria of the genus Pseudomonas are ubiquitous inhabitants of soil, water, plant surfaces, and
animal tissues; this phenomenon is due to their ability to establish in diﬀerent niches (Walker
et al., 2004; Perkins et al., 2010), and is driven mainly by their high metabolic versatility (Oberhardt
et al., 2008). Pseudomonas aeruginosa is an opportunistic pathogen of humans, animals, and plants
(Green et al., 1974; Cao et al., 2001; Attila et al., 2008; Sheng et al., 2012). They are also a frequent
cause of hospital-acquired infections, including ventilator associated pneumonia (Chastre and
Fagon, 2002) and catheter infections in immuno-compromised patients, in addition they are the
main cause of mortality in cystic ﬁbrosis (CF) patients (Høiby, 2002; McGuigan and Callaghan,
2015). P. aeruginosa strains are often highly resistant to antibiotic treatment and are therefore very
diﬃcult to eradicate once established in the host (Høiby et al., 2010; Bodro et al., 2015).
Strains of the species Pseudomonas putida are frequent rhizosphere and freshwater inhabitants
and exhibit an amazing ability to metabolize a wide range of biogenic and xenobiotic compounds
(Fernández et al., 2012; Udaondo et al., 2013). Several strains of this species have been isolated from
patients who have acquired infections in hospital environments. Infections caused by P. putida are
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rare and are mostly reported in immuno-compromised
individuals, such as those with neutropenia, newborns, and
cancer patients (Lombardi et al., 2002; Kim et al., 2012; Erol
et al., 2014). Most isolates exhibit resistance to certain antibiotics
through the presence of plasmids bearing the genes that encode
antibiotic resistance factors (Molina et al., 2014), which can be
transferred to other microorganisms in hospital environments
(Martino et al., 1996; Yoshino et al., 2011).
Despite the fact that P. putida may cause healthcare-related
infections, clinical data on P. putida infections is scarce;
this likely due to the rarity, relatively lower virulence, and
higher antimicrobial susceptibility of P. putida compared to P.
aeruginosa (Blazevic et al., 1973; Carpenter et al., 2008; Yoshino
et al., 2011). The recent emergence of multi-drug-resistant
(MDR) and carbapenem-resistant P. putida has become a cause
for concern (Almuzara et al., 2007; Bennett et al., 2009); although
this has not been extensively investigated (Kim et al., 2012).
Our group recently reported the antibiotic resistance
determinants of HB3267, a P. putida strain isolated at the Jean
Minjoz Hospital (Besançon, France; Molina et al., 2014). In fact,
HB3267 is one of several P. putida strains that were isolated
from inpatients at this hospital and multilocus sequence typing
(MLST) let us distinguish at least four diﬀerent types: HB13667,
HB8234, HB4184, and HB3267. In this study we evaluated
the potential risk of infection and pathogenicity of the four
P. putida strains isolated from the clinical samples. Analysis
included antibiotic resistance proﬁles and bioﬁlm formation.
Pathogenicity and virulence were tested using diﬀerent biological
models (human tissue and insect cultures); in all model systems,
one of these strains, HB3267 (present in several clinical samples
from Jean Minjoz Hospital), showed the ability to cause damage
to the host, and exhibited resistance to a large number of
antibiotics. The other isolates exhibited a proﬁle of resistant to a
number of antibiotics of clinical use. HB8234 had a deleterious
eﬀect on tissue cultures and in vivo mammalian cultures, but
not on insect larvae, while HB4184 only caused damage ex vivo
in human tissue culture. One isolate, HB13667 did not cause
harm to the host in the models tested. Our data indicate that
although P. putida may be associated with clinical disease, there
is in fact a great deal of variability amongst strains in regard to
drug resistance and pathogenicity.
Results
Clinical Strains P. putida Species Confirmation
Eight clinical isolates pre-identiﬁed as P. putida at the Jean
Minjoz Hospital (Besançon, France; Table 1) were subjected to
a set of tests to verify that they belong to this species. The
tests included: (a) Sequence analysis of DNA 16S fragment
>500 bp, according to Janda and Abbott (2007); (b) biochemical
identiﬁcation using API 20E tests (BioMerieux, Inc.), and
(c) PCR ampliﬁcation of species-speciﬁc repetitive extragenic
palindromic sequences for P. putida (REPc proﬁle), which
enables us to identify exclusively P. putida strains and even
discriminate among diﬀerent strains (Aranda-Olmedo et al.,
2002).
TABLE 1 | Bacterial strains used in this study.
Species Strain Source Reference
Pseudomonas putida
Hospital Besançon
isolates
HB13667 Bacteraemia/co-isolated
with Enterobacter cloacae
This study
HB8234 Bacteraemia Molina et al.
(2013)∗
HB3304 Cystic fibrosis This study
HB4184 Cystic fibrosis This study
HB4477 Urinary infection This study
HB4557 Urinary infection This study
HB3536 Faeces This study
HB3267 Deceased in-patient Molina et al.
(2014)
Environmental strain KT2440 Lab. Collection
Pseudomonas
aeruginosa
PAO1 Lab. Collection
Escherichia coli DH5α Lab. Collection
∗Strain was firstly denoted as H8234.
All the rRNA16S gene sequences analyzed exhibited
similarities of at least 99% with P. putida strains available
on database. In addition, the eight strains were positively
identiﬁed as P. putida by the API tests; three diﬀerent REPc
proﬁles were detected, which suggested the existence of diﬀerent
P. putida strains. Taken together these results unequivocally
conﬁrmed that the hospital isolates belonged to the species
P. putida.
Multilocus Sequence Typing
With the aim of determining how similar the clinical isolates
were at the genetic level and the phylogenetic relationship among
them and other P. putida strains we performed MLST using
the complete sequence of ﬁve highly conserved genes: ropD,
gyrB, edd, recA, and trpF (which in total sum more than 7 kb).
When the resulting sequences were compared using BLAST,
in all cases maximum likelihood similarities were found with
respective to homologous genes in P. putida soil isolates, however,
the similarities did not reach 100%, indicating that these clinical
strains were diﬀerent from soil isolates.
After analyzing the sequences by Local Comparison using
the Clone Manager Suite 7 program, the results allowed us
to establish ﬁve allelic types and a three-branch phylogenetic
tree (Figure 1). Four of the isolates belonged to the same
allelic type: HB4477, HB4557, HB3536, and HB3267; all of
them also harbored a 80 kb megaplasmid and exhibited a
similar antibiotic resistance proﬁle (see below), this data suggests
that they represent diﬀerent isolates of the same strain, we
therefore randomly chose HB3267 as a representative of this
group. Although HB13667 was phylogenetically close to the
HB3267 group, the absence of the megaplasmid in this strain
and a diﬀerent antibiogram (see below) led us to consider
it independently. HB4184, isolated from a CF patient, was
dissimilar enough to be considered a diﬀerent subgroup. HB8234
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and HB3304 were found to be phylogenetically very similar when
compared to the other clones; HB3304 was omitted from further
analysis because we had already chosen a CF patient isolate.
In summary and based on the above set of results, we chose
HB13667, HB8234, HB4184, and HB3267 as representatives of
the respective subgroups for further analysis.
Study of Potential Pathogenic Traits in
P. putida Clinical Strains
Antibiotic Resistance Profile
Antibiotic resistance tests were performed in solid medium using
commercial antibiotic discs; a total of 31 antimicrobials were
assayed. Results (Supplementary Table S1) showed two distinct
antibiotic resistance proﬁles: (a) clones resistant to a high number
(around 84%) of the antibiotics tested, this was the HB3267 strain
(the same proﬁle was seen with HB4477, HB4557, and HB3536).
HB3267 (as well as HB4477, HB4557, and HB3536) harbor an
80 Kb megaplasmid, pPC9, previously shown to be required for
antibiotic resistance (Molina et al., 2014) and (b) the rest of the
clones were resistant to half of the antibiotics tested; no plasmid
was found in isolates belonging to this second group of clones.
Analysis of the Ability to form Biofilms
Many pathogenic bacteria are highly resistant to antibiotic
treatment, and one important antibiotic resistance mechanism is
the formation of bioﬁlms (Høiby et al., 2001; Tseng et al., 2013).
To assess the capacity to form bioﬁlms, the hospital isolates of
P. putida were cultured in 24-well plates for 6 h, followed by a
quantiﬁcation of bioﬁlm formation (see Materials and Methods).
FIGURE 1 | Phylogenetic tree. Multi-way DNA alignment of the
concatenated housekeeping gene sequences.
The relative amount of bioﬁlm produced by the four strains
is shown in Figure 2. HB4184 produced very dense bioﬁlms
with the surfaces coverage being higher than that of the positive
control, P. aeruginosa PAO1. The other three strains (HB13667,
HB8234, and HB3267) showed a limited ability to form bioﬁlms.
Ex Vivo Effects of P. putida Strains on Human
Skin Cultures
Determination of Cell Viability by DNA and LDH
Quantification
The eﬀect of P. putida hospital isolates on human skin cell
cultures was determined by quantifying the amount of DNA and
lactate dehydrogenase (LDH) released by damaged cells. This
analysis revealed that all strains were able to increase the amount
of DNA released from skin cells to the culture medium; the
results corresponding to HB8234, HB4184, and HB3267 were
signiﬁcantly higher than negative controls (P < 0.05; Table 2).
Interestingly, the amount of DNA released from cell cultures
incubated with the HB3267 strain was very similar to the positive
control tissues which were treated with triton X-100 (Table 2).
Histological Analysis of Human Skin Samples
Incubated with P. putida Strains
The histological analysis of human skin fragments incubated
in the presence of the diﬀerent bacteria strains showed that all
strains were able to alter the structure of both the epithelium and
the stromal layer of the human skin, this was particularly notable
for strains HB8234, HB4184, and HB3267. In all cases, we found
vacuolization and nuclear degeneration of epithelial cells along
with dermal disorganization when compared to control human
skin (Figure 3).
TABLE 2 | Analysis of cell viability of human skin samples incubated in the
presence of the different P. putida strains.
HB13667 HB8234 HB4184 HB3267 Triton-
X∗
PBS∗∗
Percentage of
DNA released
16.25 27.12 15.02 95.64 100.00 0.00
Percentage of
LDH released
12.30 24.71 17.52 32.52 100.00 0.00
Cytotoxicity was determined by DNA and LDH release after 24 h of infection. ∗Triton
X-100 detergent was used as a positive control (100% cell death). ∗∗Bacteria-free
PBS was used as a negative control (100% cell survival).
FIGURE 2 | Biofilm formation. Bacterial biofilms stained with crystal violet.
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FIGURE 3 | Histological analysis of human skin using light microscopy, samples incubated with the different Pseudomonas putida strains (HB13667,
HB8234, HB4184, and HB3267) and control non-inoculated skin (CTR). All samples were stained with hematoxylin and eosin.
Immunohistochemistry and Immunofluorescence for
Epithelial Cell Markers
In order to determine if the strains were capable of
disrupting the epithelial layers, we tested important structural
proteins of the skin using immunohistochemistry and
immunoﬂuorescence. Immunohistochemical detection of
laminin, which is one of the most important components
of the basement membrane of the epithelium, showed
signiﬁcant alterations of the dermal-epidermal junction of
tissues incubated with the diﬀerent strains, as shown in
Figure 4. The most damaged laminin was found for HB3267,
which showed a clear separation of the epithelial and stromal
layers.
When two speciﬁc proteins with a key role in cell-
cell attachment (ZO-2 and desmoplakin) were analyzed by
immunoﬂuorescence, we found that the signal intensity of both
components of the cell-cell junction complex were reduced
after exposer to the diﬀerent P. putida strains (Figure 5).
Incubation of the human skin tissues in the presence of HB13667,
HB8234, and HB3267 signiﬁcantly reduced the expression of
ZO-2, a key component of the tight junctions which maintain
the barrier function of the human skin. We also found that
FIGURE 4 | Analysis of the integrity of the basement membrane of human skin samples incubated with the different P. putida strains (HB13667,
HB8234, HB4184, and HB3267) and control non-inoculated skin (CTR) using laminin immunohistochemistry. Positive signal is labelled in brown and
highlighted with arrows.
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FIGURE 5 | Analysis of the integrity of epithelial cell-cell junctions as
determined by immunohistofluorescence for ZO-2 (upper) and
desmoplakin (lower) in human skin samples incubated with the different
P. putida strains (HB13667, HB8234, HB4184, and HB3267) and control
non-inoculated skin (CTR). Positive signal is labelled in green and cell nuclei
have been counterstained in red.
desmoplakin, a protein with an important role in cell-cell
attachment via adherent junctions, was altered in skin incubated
in all strains; again this was especially noticeable in the presence
of HB3267.
Immunohistochemistry for Immune-System Cell
Markers
To determine the immune response initiated by the presence
of the diﬀerent strains in vitro, we analyzed several immune-
related markers using immunohistochemistry in controls
and skin incubated with the diﬀerent bacterial strains.
The results of this analysis showed increased expression of
TABLE 3 | Percentage of dermal cells showing positive expression of
tumor necrosis factor (TNF), interleukin 1A (IL-1A), interleukin 6 (IL-6), and
interferon (IF) in human skin samples inoculated with the different
P. putida strains (HB13667, HB8234, HB4184, and HB3267) and control
non-inoculated skin as determined by immunohistochemistry.
Marker HB13667 HB8234 HB4184 HB3267 Control
TNF 15–20% 5–10% 10–15% 30–40% 5–10%
IL-1A 5–10% 5–10% 5–10% 5–10% 5–10%
IL-6 20–30% 20–30% 20–30% 30–40% 20–30%
IF 5–10% <5% 5–10% 10–20% 20–30%
TNF-positive cells in the dermis of human skin incubated
in HB4184 and HB3267. At the same time, we also
found that samples in which the HB3267 strain had been
inoculated had higher number of cells which showed
positive expression of IL-1A, IL-6, and IF in the dermal
layer (Table 3).
In Vivo Effects of the P. putida Strains on a
Mammalian Model
The eﬀects of the P. putida strains were evaluated in vivo on
the skin of Wistar laboratory rats. Clinical analysis of the skin
of animals in which the diﬀerent strains had been inoculated
did not reveal any macroscopically detectable skin damage in
any of the groups. However, histological analysis demonstrated
the existance of structural diﬀerences between the samples. In
accordance with P. putida being an opportunistic pathogen,
none of the animals with intact skin displayed any histological
alteration, however, the inoculation of certain bacteria on
the rat skin previously damaged with liquid nitrogen was
associated with diﬀerent levels of tissue organisation (Figure 6).
Speciﬁcally, the skin epidermis was seriously damaged in samples
treated with HB3267 and, at lesser extent, HB8234. In both
cases, the epithelial damage was signiﬁcantly higher than that
observed for control skin inoculated with the positive control
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FIGURE 6 | In vivo analysis of the effects of the different
P. putida strains (HB13667, HB8234, HB4184, and HB3267) and
controls on intact rat skin (A) and freeze-injured rat skin (B).
All samples were fixed in formalin, stained with hematoxylin-eosin
and analyzed using a light microscope. CTR: control non-inoculated
skin. KT-2440: skin inoculated with non-pathogenic KT-2440 strains
(negative control). PAO1: skin inoculated with P. aeruginosa (positive
control).
-P. aeruginosa- and the negative control -KT2440- in the
same animals with a liquid nitrogen freeze injury. The same
trend was found in the dermis, although the damage was
less intense than in the epidermis, with the exception of skin
treated with HB3267, where a high percentage of connective
tissue was damaged and lost after 24 h of incubation with this
strain.
Effects of P. putida Clinical Strains on an
Insect Model: Chrysoperla carnea
Chrysoperla carnea larvae were put in contact with bacterial
strains PAO1, KT2440, and clinical isolates HB13667, HB8234,
HB4184, and HB3267. P. aeruginosa PAO1, used as positive
control, gave a 94% mortality rate, with a 82% of mortality
within 2 days of inoculation (89.3% of the total of deaths;
Figure 7). As expected, the environmental strain KT2440 had a
minimal eﬀect on larvae mortality, with <20% mortality after
12 days incubation, a similar eﬀect was seen with the HB13667,
HB8234, and HB4184 clinical isolates. In contrast, only 48% of
the larvae exposed to the strain HB3267 survived; an importantly
a high rate of mortality was observed between days 3 and 5
following inoculation with 64.7% of the total deaths occurring
in this period (Figure 7). The Cox model revealed statistically
signiﬁcant diﬀerences between the risks of mortality produced
by PAO1 and HB3267, and between these two and the other
P. putida tested (Table 4). Therefore, only PAO1 and HB3267
showed an increase mortality risk than the control. The eﬀect of
the frailty term was not signiﬁcant in the model, indicating no
diﬀerence between experimental runs over time.
Discussion
Infections caused by multidrug-resistant Gram-negative bacteria
have become a growing challenge in hospital environments;
in fact these microorganisms cause a higher number of
nosocomial infections than resistant Gram-positive bacteria
(methicillin-resistant Staphylococcus aureus or vancomycin-
resistant Enterococcus species; Leneveu-Jenvrin et al., 2013;
Ott et al., 2013). P. putida strains are seldom isolated from
clinical samples, suggesting that they survive in the hospital
setting and occasionally cause nosocomial infections in severely
ill or immuno-compromised patients (Carpenter et al., 2008;
Treviño et al., 2010; Liu et al., 2014). Nevertheless, there are
no published studies focused on evaluating the pathogenicity of
P. putida clinical strains and the diﬀerences between clinical and
environmental P. putida isolates have not been established. This
study aimed to evaluate the pathogenic potential of P. putida
isolates from in-patients at Besançon Hospital using diﬀerent
biological models.
To explore putative phenotypic diﬀerences among
environmental and clinical isolates, the well-known
environmental strain P. putida KT2240 was included as a control
in this study. KT2440 is a biologically safe microorganism
Frontiers in Microbiology | www.frontiersin.org 6 August 2015 | Volume 6 | Article 871
Fernández et al. Low infectivity and virulence of Pseudomonas putida strains
FIGURE 7 | Cumulative survival of Chrysoperla carnea larvae treated
with different P. putida clinical strains.
TABLE 4 | Hazard ratios of C. carnea larvae in contact with P. putida
clinical strains. Cox model analysis.
Factor Hazard
ratio
95%Confidence
interval
Wald chi-
square
df P
Treatmenta 244.5 6 <0.001
LB control (A) 1.00
KT2440 (B) 0.80 0.36–1.77 0.30 1 0.580
HB13667 (C) 0.97 0.46–2.03 0.01 1 0.930
HB8234 (D) 1.10 0.53–2.28 0.07 1 0.800
HB4184 (E) 0.54 0.23–1.29 1.90 1 0.170
HB3267 (F) 2.87 1.52–5.41 10.68 1 0.001
PAO1 (G) 21.25 11.55–39.10 96.56 1 <0.001
Blockb 6.12 3.03 0.110
aPairwise comparisons of treatments: B – C, P = 0.640; B – D, P = 0.430; B – E,
P = 0.400; B – F, P< 0.001; B – G, P < 0.001; C – D, P = 0.730; C – E, P = 0.190;
C – F, P < 0.001; C – G, P < 0.001; D – E, P = 0.110; D – F, P = 0.002; D – G,
P < 0.001; E – F, P < 0.001; E – G, P < 0.001; F – G, P < 0.001.
bVariance of random effect = 0.0415.
as declared by the Recombinant DNA Advisory Committee
and it is considered a model microorganism for a variety of
process (Fernández et al., 2012). Indeed, we conﬁrm here that
KT2440 did not damage host cells, in either ex vivo or in vivo
experiments, where its presence was indistinguishable from
bacteria-free negative controls.
Variation in the Pathogenic Potential of
P. putida Clinical Strains
Taken together, data from this study, have revealed the variability
in the pathogenic traits exhibited between the P. putida strains
tested; this variability is consistent with the number of phylogenic
types found.
HB3267
Among the clinical strains tested the highest pathogenic potential
was associated with HB3267, which exhibited pathogenic traits in
almost all of the assays: it had a cytotoxic eﬀect on human skin
cells, it caused damage to the epithelial layer, and it provoked
an immune-system response. When inoculated into wounds on
rats HB3267 caused severe damage to the epidermis and the
underlying connective tissue. Finally, it showed a deleterious
eﬀect on the survival of C. carnea larvae.
Molina et al. (2014) showed that this strain was
phylogenetically closed to the nicotine degrader P. putida
S16 (Wang et al., 2007) but phylogenetically distant from
P. aeruginosa strains. In our in vivo experiments the pathogenic
nature of HB3267 showed low coincidence with those found
for PAO1: HB3267 caused more serious damage on the injured
skin of rats than PAO1, but it caused a lower mortality of
C. carnea larvae which also occurred at diﬀerent stages of insect
development. This suggests the potential existence of diﬀerent
mechanisms of virulence in both species.
HB3267 (or variants of this strain) were isolated from four
diﬀerent patients at the Besançon Hospital, the rest of strains
tested were isolated only once. This ﬁnding could be linked to its
innate resistance to most of the antibiotics tested, since antibiotic
resistance is considered a key factor in nosocomial prevalence
(Bereket et al., 2012). Previous studies from our research group
showed that HB3267 antibiotic resistance is encoded both on
the chromosome and the pPC9 plasmid (Molina et al., 2014).
The pPC9 plasmid is not self-transmissible but can be mobilized
by other bacterial plasmids, a factor which increases the risk
of the spread of drug resistance genes via horizontal gene
transfer to new hosts including more pathogenically important
species (Molina et al., 2014). In addition, Molina et al. (2014)
showed that segments of the plasmid could have been acquired
from human opportunistic pathogens or primary pathogens,
such as P. aeruginosa, Aeromonas hydrophila, Acinetobacter
baumannii, Corynebacterium resistens and Enterobacteriaceae
(Klebsiella pneumoniae, Salmonella enterica). The presence of
this exogenous DNA, including its high number antibiotic
resistance cartridges, suggests a history of evolution in medical
environments for HB3267.
HB8234
Strain HB8234 revealed pathogenic potential on human skin
tests, where it caused cytotoxicity and histological disorders; in
addition, it further damaged the injured skin of Wistar rats, but it
did not aﬀect larvae survival. HB8234was also sequenced recently
by our research group (Molina et al., 2013) and it was found
that the genome of this strain is signiﬁcantly larger than other
P. putida genomes (1.0 Mb larger), with most of the accessory
DNA organized into 44 genetic islands, and having low or no
homology to other P. putida genomes. This suggests that genome
evolution in P. putida species is linked to the niche where these
microbes develop.
HB4184
This strain showed pathogenic traits, but only on human skin,
where it caused a moderate cytotoxicity, histological damage and
triggered an immune response. It did not cause damage on the
skin of Wister Rats and did not aﬀect insect survival. Taken
together, these data reveal that HB4184 has a lower pathogenic
potential than HB3267 or HB8234, however, its ability to form
bioﬁlms, which is superior to that of P. aeruginosa PAO1, is
a worrisome trait. Nosocomial infections are often linked to
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devices surfaces that are colonized by bioﬁlms (Abdallah et al.,
2014); in fact, Carpenter et al. (2008) found that 93% of the
reported cases of infections with P. putida were associated with
the use of invasive medical devices. Bacterial bioﬁlms are diﬃcult
to eradicate, since bacteria in bioﬁlm exhibit higher resistance to
antibiotic and disinfectant agents. Wang et al. (2010) found that
urinary catheters were colonized by a mixed bioﬁlm of S. aureus,
P. aeruginosa, Escherichia coli, and K. pneumoniae. These mixed
bacterial bioﬁlms in medical environments represent the most
favourable place for the exchange genetic material between
clinical strains with the consequent risk of new pathogenic strains
arising.
HB13667
Strain HB13667 did not show pathogenic traits in any of the
biological systems used in this study. HB13667 was associated
with a strain of Enterobacter cloacae in the original clinical
sample; it is possible that HB13667 was a merely coexisting
and not associated with the clinical sequelae. In any case, the
non-pathogenic character found for HB13667 is representative
of most P. putida strains, but, as we have shown in this study,
some dangerous traits can be acquired when the strains evolve in
medical environments.
In short, our result show that P. putida isolated from clinical
samples vary in their proﬁle of antibiotic resistance and that, as
for other microorganisms, horizontal gene transfer via plasmid is
relevant in the clinical environment. Our data support the notion
that the arsenal of accessory genes found in a clinical bacterial
isolate is related to the environment in which those microbes
develop and that strains of P. putida harbour a mosaic of genes
often based on DNA exchange.
Materials and Methods
Bacterial Strains and Growth Conditions
Bacterial strains used in this work are listed in Table 1. P. putida
clinical strains were isolated from clinic samples at Hospital
Jean Minjoz (Besançon, France) and pre-identiﬁed as belonging
to P. putida. Pseudomonas strains were routinely grown in
Luria-Bertani (LB) medium at 30◦C with shaking, unless other
conditions are mentioned. P. aeruginosa PAO1 and E. coli were
grown at 37◦C.
Identification and Typing of Strains using DNA
Techniques
Chromosomal DNA was isolated using the Wizard Genomic
DNA Puriﬁcation Kit (Promega, USA). PCR ampliﬁcations were
performed according to standard procedures using Euro Taq
polymerase (EuroClone, Italy).
16S rDNA ampliﬁcation was performed using the F8 and
R798 primers (Liu et al., 2008). The REPc method allows the
identiﬁcation of P. putida strains (Aranda-Olmedo et al., 2002)
since this primer ampliﬁes only DNA from this species, and
generates products of diﬀerent size for each strain. Previously
optimized PCR conditions were used (Aranda-Olmedo et al.,
2002). Positive (P. putida KT2440) and negative (E. coli) DNA
controls were included.
Multilocus sequence typing was carried out using a set
of primers (listed in Supplementary Table S2) to amplify the
complete sequence of ﬁve housekeeping genes: RNA polymerase
sigma factor rpoD (1851 pb), DNA gyrase subunit B gyrB
(2241 pb), N-(5′-phosphoribosyl) anthranilate isomerase trpF
(621 pb), 6-phosphogluconate dehydratase edd (1827 pb), and
recombinase A recA (1068 pb) as previously reported (Frapolli
et al., 2007; Khan et al., 2008).
Antibiotic Resistance Profile
Antibiograms were performed with commercial discs
(Biomerieux); 31 diﬀerent antibiotics were tested. Overnight
bacterial cultures were spread on 240 mm × 240 mm LB plates,
air dried in a laminar ﬂow and then discs containing antibiotics
were placed on the LB plates. Plates were incubated at 30◦C
for 16–18 h. Halos surrounding the discs were measured as an
indication of inhibition of growth. Assays were repeated at least
three times in duplicate.
Semi-quantitative Determination of Biofilm
Formation
Semi-quantitative determination of bioﬁlm formation was
performed as previously described (Christensen et al.,
1985). Experiments were conducted in 24 well ﬂat-bottomed
polystyrene microtitre plates using M9 minimal medium
supplemented with 0.2% glucose and 0.4% casamino acids in the
presence of diﬀerent Pseudomonas strains. Bioﬁlm formation
was quantiﬁed after 6 h by staining with crystal violet using
the technique described by O’Toole and Kolter (1998). Two
independent experiments were carried out for each strain and
experiments run in quadruplicate.
Ex Vivo Evaluation of the Different P. putida
Strains on Human Skin
Live human skin was obtained from male patients subjected to
circumcision surgery under local anesthesia. Once obtained, the
skin was divided into 8 mm-diameter circular pieces using a
biopsy punch, and kept submerged at 37◦C in culture medium
(DMEM with 10% fetal calf serum and antibiotics) for 2 h.
Informed consent was obtained for the use of the skin in this
study. This study was approved by the local research and ethics
committee.
To determine the biological eﬀects of each P. putida strain
on cell viability of the human skin, 105 cells of each strain were
diluted in 20 μl of PBS and placed on the epithelial surface of
each skin fragment. PBS without bacteria was used as negative
control and 2% Triton X-100 detergent (Sigma, St. Louis, MO,
USA) was used to induce cell death (positive control). In all cases,
culture mediumwas added after 10min and tissues were cultured
at 37◦C in a tissue incubator for 24 h.
To determine cell viability at the structural level, DNA and
LDH quantiﬁcation methods were used as previously described
(Oliveira et al., 2014). Brieﬂy, 10 μl of culture medium was
diluted in nuclease-free distilled water to a ﬁnal volume of
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100 μl and free DNA was quantiﬁed using a SmartSpecTM
plus Spectrophotometer (BIO-RAD, Hercules, CA, USA) at 260–
280 nm. For LDH quantiﬁcation, 100 μl of culture medium
was added to 100 μl of a commercially available immunological
Cytotoxicity Detection Kit (Roche Applied Science, Mannheim,
Germany), and the presence of the cytoplasmic enzyme was
detected by colorimetric assay using an ELX-800 plate reader
(Biotek, Winooski, VT, USA). Each sample was measured ﬁve
times.
In Vivo Evaluation of the Clinical P. putida
Strains in Animal Models
The in vivo eﬀects of the P. putida strains were evaluated on the
skin of 12 Wistar laboratory rats. First, the dorsal skin of each
animal was shaved and 105 cells corresponding to each strain
and control pathogenic bacteria (P. aeruginosa PAO1) and non-
pathogenic bacteria (P. putida KT2440) were applied along with
a non-bacterial control (PBS). To facilitate the entry of each
bacterial strain into the rat skin, a freeze injury was generated at
the site of the implant in half of the animals by using a metal rod
submerged in liquid nitrogen for 30 s. All animals were evaluated
and euthanized 24 h post-treatment for histological analysis.
Histological Analysis and
Immunohistochemistry
Human and rat skin samples evaluated in this work were ﬁxed in
4% (v/v) formaldehyde, dehydrated in ethanol and embedded in
paraﬃn for histological analysis. In all cases, 4 μm-thick sections
were obtained and stained in hematoxylin and eosin and analyzed
using a light microscope. For scanning electron microscopy,
tissues were ﬁxed in cacodylate-buﬀered 3% glutaraldehyde,
dehydrated in increasing concentrations of acetone (30, 50, 70,
95, and 100%), critical-point dried, gold sputter-coated and
analyzed in a scanning electron microscope (Quanta 200; FEI,
Eindhoven, The Netherlands), using high vacuum mode.
Analysis of intercellular junctions was carried out by
immunoﬂuorescence with speciﬁc anti-zonula occludens 2
or anti-desmoplakin primary antibodies, and FITC-labeled
secondary antibodies. Samples were analyzed using a confocal
microscope. Evaluation of laminin, interleukin 1A (IL-1A) and
6 (IL-6), interferon (IFN) and tumor necrosis factor (TNF)
was performed by immunohistochemistry. Brieﬂy, tissue sections
were deparaﬃnized, incubated in pH 6 citrate buﬀer for 40min at
95◦C for antigen retrieval, and primary antibodies were applied
for 60 min at room temperature. Secondary antibodies were
applied and the reaction was developed using a commercial
3-3′ diaminobenzidine kit (Vector Laboratories, Burlingame,
CA, USA). Finally, samples were counterstained in Mayer’s
hematoxylin and mounted on coverslips for light microscopy
evaluation.
Evaluation of the Clinical P. putida Strains
using Insect Models
A stock colony of C. carnea (Stephens) has been maintained
at the Estación Experimental del Zaidín since 2005 from larvae
supplied by Koppert Spain (La Mojonera, Almería). On arrival
larvae were individually transferred to petri dishes and reared
on eggs of Ephestia kuehniella Zeller purchased from Biotop
(Valbonne, France). After emergence, adults were placed inside
plastic rearing boxes (approximately 100 specimens per box) with
access to mineral water and an artiﬁcial diet consisting of 50%
honey and 50% pollen spread over ﬁlter paper and sprinkled with
quartz grains. The food and water were replenished weekly. The
stock colony was maintained in a controlled environment cabinet
at 25± 1◦C, 50–60% relative humidity, and a photoperiod of 16:8
light:dark (L:D) h. New individuals were added monthly with an
additional larvae supply.
Chrysoperla carnea larvae used in the experiments were
obtained from eggs laid onto the removable lid of the rearing
boxes. Over 300 eggs were collected, kept in individual Petri
dishes (4.5 cm diameter), and allowed to develop. Larvae were
supplied with E. kuehniella eggs ad libitum every other day.
Eleven days after egg collection, 70 recently molted (less than
12 h) third instar larvae, of approximately the same length
(4–6 mm) and weight (2–4 mg), were chosen for the experiment
and allocated randomly (10 individuals) to each treatment. The
larvae were then placed in pairs on solid LB agar on which 0.1
mlof a 108 CFU/ml culture had been spread (ﬁve dishes per
treatment) and kept in contact with the bacteria for an hour.
The larvae were allowed to move freely on the agar surface but,
whenever they climbed to the lid, this was tapped gently to
make them fall, restricting their movement to the bottom assured
maximum contact with the bacteria throughout the process.
Once the inoculation process ﬁnished, the larvae were transferred
individually to new Petri dishes, supplied with food, and kept
again under standard larvae culture conditions. Larval and pupal
mortality was assessed twice daily until emergence of the pharate
adult. Pupal mortality inside the cocoon was recorded whenever
the pupae started to blacken. The experiment used a randomized
complete block design running the whole experiment up to six
times (60 individuals per treatment).
Survival data was analysed using a frailty Cox proportional
hazards model (Therneau and Grambsch, 2000). The blocking
structure for experimental run was included in the model as
a frailty term with a Gaussian error distribution. The frailty
approach incorporates the frailty terms as random eﬀects in the
Cox proportional hazards model to control for the correlation
in clustered survival data as is the case for each experimental
run. The analysis was carried out using R software for windows
(R Development Core Team, 2010) with functions from the
packages survival and splines.
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